Cost-Benefit Analysis of Sustained-Release Bupropion, Nicotine Patch, or Both for Smoking Cessation
- 1 March 2000
- journal article
- Published by Elsevier in Preventive Medicine
- Vol. 30 (3), 209-216
- https://doi.org/10.1006/pmed.1999.0627
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR Guideline for Smoking CessationJAMA, 1997
- The Health Care Costs of SmokingNew England Journal of Medicine, 1997
- Leaving work to smokeAddiction, 1997
- Short-term Economic and Health Benefits of Smoking CessationCirculation, 1997
- The Cost-Effectiveness of the Nicotine Transdermal Patch for Smoking CessationPreventive Medicine, 1997
- The Effectiveness of the Nicotine Patch for Smoking CessationJAMA, 1994
- The Effects of Behavioral Risks on Absenteeism and Health-Care Costs in the WorkplaceJournal of Occupational and Environmental Medicine, 1991
- Quitting Smoking in the United States in 1986JNCI Journal of the National Cancer Institute, 1990
- How much can business expect to profit from smoking cessation?,Preventive Medicine, 1983